Thus, this analysis aimed to evaluate the cost-effectiveness of routine HCC surveillance using GALAD, GAAD, and PIVKA-II plus AFP (PIVKA-II + AFP) compared to US + AFP or no routine surveillance amongst Thai patients with compensated liver cirrhosis (CLC). Here, AFP is linked to hepatocellular carcinoma.